143 related articles for article (PubMed ID: 8086271)
1. PAPNET for analysis of proliferating (MIB-1 positive) cell populations in cervical smears.
Boon ME; Kleinschmidt-Guy ED; Ouwerkerk-Noordam E
Eur J Morphol; 1994 Mar; 32(1):78-85. PubMed ID: 8086271
[TBL] [Abstract][Full Text] [Related]
2. Recognition of atypical reserve cell hyperplasia in cervical smears and its diagnostic significance.
Boon ME; van Dunné FM; Vardaxis NJ
Mod Pathol; 1995 Sep; 8(7):786-94. PubMed ID: 8539239
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of computer-assisted primary cervical smear screening: a longitudinal cohort study.
Doornewaard H; van der Schouw YT; van der Graaf Y; Bos AB; Habbema JD; van den Tweel JG
Mod Pathol; 1999 Nov; 12(11):995-1000. PubMed ID: 10574595
[TBL] [Abstract][Full Text] [Related]
4. Semiautomatic PAPNET analysis of proliferating (MiB-1-positive) cells in cervical cytology and histology.
Boon ME; Beck S; Kok LP
Diagn Cytopathol; 1995 Dec; 13(5):423-8. PubMed ID: 8834316
[TBL] [Abstract][Full Text] [Related]
5. Microwave-antigen retrieval for proliferation analysis (MIB-1) and quanticyt karyometry of bladder washings.
Van der Poel HG; Boon ME
Eur J Morphol; 1994 Mar; 32(1):71-8. PubMed ID: 8086270
[TBL] [Abstract][Full Text] [Related]
6. Upgrading unsatisfactory cervical smears with the MiB-1 method.
Boon ME; Kleinschmidt-Guy ED; Wijsman-Grootendorst A; Hoogeveen MM
Diagn Cytopathol; 1996 Nov; 15(4):270-6. PubMed ID: 8982579
[TBL] [Abstract][Full Text] [Related]
7. Prospective and randomised public-health trial on neural network-assisted screening for cervical cancer in Finland: results of the first year.
Nieminen P; Hakama M; Viikki M; Tarkkanen J; Anttila A
Int J Cancer; 2003 Jan; 103(3):422-6. PubMed ID: 12471627
[TBL] [Abstract][Full Text] [Related]
8. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
9. Consequences of neural network technology for cervical screening: increase in diagnostic consistency and positive scores.
Kok MR; Boon ME
Cancer; 1996 Jul; 78(1):112-7. PubMed ID: 8646706
[TBL] [Abstract][Full Text] [Related]
10. [Diagnosis of cervical dysplasias].
Pérez Dettoma J; Santamaría M; Jurado M; Cabezón C; Domínquez J; de la Fuente F; López García G
Rev Med Univ Navarra; 1980 Dec; 24(4):26-9. PubMed ID: 7336009
[No Abstract] [Full Text] [Related]
11. [Cytological classifications of vaginal smears. Current concepts of complex cytodiagnosis].
Kasabova M
Akush Ginekol (Sofiia); 1984; 23(4):357-64. PubMed ID: 6385754
[No Abstract] [Full Text] [Related]
12. DNA-cytometric diagnosis of prospective malignancy in borderline lesions of the uterine cervix.
Böcking A; Hilgarth M; Auffermann W; Hack-Werdier C; Fischer-Becker D; von Kalkreuth G
Acta Cytol; 1986; 30(6):608-15. PubMed ID: 3466496
[TBL] [Abstract][Full Text] [Related]
13. Significance of MiB-1 staining in smears with atypical glandular cells.
Boon ME; Vinkestein A; van Binsbergen-Ingelse A; van Haaften C
Diagn Cytopathol; 2004 Aug; 31(2):77-82. PubMed ID: 15282717
[TBL] [Abstract][Full Text] [Related]
14. Proliferation patterns of cervical cells as visualized in Leiden liquid cytology slides.
Luzzatto L; van Haaften C; Boon ME
Diagn Cytopathol; 2004 Jul; 31(1):5-9. PubMed ID: 15236256
[TBL] [Abstract][Full Text] [Related]
15. [Biometric research in the diagnosis of precancerous states and endocervical cancer].
Novik VI; Agroskin LS; Papaian GV; Solov'eva LV
Arkh Patol; 1989; 51(12):45-50. PubMed ID: 2629663
[TBL] [Abstract][Full Text] [Related]
16. The occurrence of isolated dysplastic and carcinoma in situ type cells in cervical smears from patients with dysplasia and carcinoma in situ: significance to prescreening using image processing techniques.
Feldman M; Poulsen R; Shepherd L; Marshall KG
Acta Cytol; 1973; 17(5):395-400. PubMed ID: 4517951
[No Abstract] [Full Text] [Related]
17. PAPNET-assisted primary screening of conventional cervical smears.
Cenci M; Nagar C; Vecchione A
Anticancer Res; 2000; 20(5C):3887-9. PubMed ID: 11268471
[TBL] [Abstract][Full Text] [Related]
18. [Condylomas, cervical dysplasias and carcinoma of the cervix (author's transl)].
de Brux J; Ionesco M; Cochard B; Masson MF; Kaeding H
J Gynecol Obstet Biol Reprod (Paris); 1980; 9(6):613-20. PubMed ID: 6257776
[TBL] [Abstract][Full Text] [Related]
19. The PAPNET system for quality control of cervical smears: validation and limits.
Cenci M; Nagar C; Giovagnoli MR; Vecchione A
Anticancer Res; 1997; 17(6D):4731-4. PubMed ID: 9494597
[TBL] [Abstract][Full Text] [Related]
20. [Argyrophilic proteins in the nucleolar organizer in the differential diagnosis of cervical dysplasias and cancer].
Diadyk EA; Vasilenko IV; Smirnova EA; Raĭkhlin NT
Arkh Patol; 1993; 55(2):23-7. PubMed ID: 7980057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
